IRVINE, Calif. -- Advanced Sterilization Products (ASP) announces that its STERRAD® CYCLESURE® Biological Indicator readout time has improved from a 48-hour incubation time to only 24 hours. Now, STERRAD® System customers can safely record biological indicator results in 50 percent less time, speeding up instrument throughput in the sterilization department. The product name is also changing to STERRAD® CYCLESURE® 24 Biological Indicator to reflect this time-saving improvement.
ASP successfully re-engineered the product after receiving feedback from customers requesting a faster incubation period. A faster incubation period keeps sterilization departments moving efficiently as well as limiting the need to purchase duplicate instrument inventories, which is frequently required when waiting for the results of a 48-hour or more biological indicator readout.
“ASP has been providing healthcare organizations with STERRAD® System technology and supplies for almost two decades,” says Karen Borg, worldwide vice president of marketing for ASP. “We are committed to continuous product innovation and are passionate about designing and marketing infection prevention solutions like the STERRAD® CYCLESURE® 24 Biological Indicator that not only meet our customers’ needs, but often exceed them.”
The STERRAD® CYCLESURE® 24 Biological Indicator can be used with all of ASP’s market-leading, low-temperature hydrogen peroxide gas plasma STERRAD® Systems: the STERRAD® 100NX™ System, STERRAD® NX™ System, STERRAD® 100S System, STERRAD® 200 System, as well as the STERRAD® 50 System. The STERRAD® CYCLESURE® 24 Biological Indicator is only validated for use in STERRAD® Systems.
For information about STERRAD® System products, ASP or ASP’s line of infection prevention solutions, visit http://www.sterrad.com or call 1-888-STERRAD.
Source: Advanced Sterilization Products (ASP)
Unmasking Vaccine Myths: Dr Marschall Runge on Measles, Misinformation, and Public Health Solutions
May 29th 2025As measles cases climb across the US, discredited myths continue to undercut public trust in vaccines. In an exclusive interview with Infection Control Today, Michigan Medicine’s Marschall Runge, PhD, confronts misinformation head-on and explores how clinicians can counter it with science, empathy, and community engagement.
Silent Saboteurs: Managing Endotoxins for Sepsis-Free Sterilization
Invisible yet deadly, endotoxins evade traditional sterilization methods, posing significant risks during routine surgeries. Understanding and addressing their threat is critical for patient safety.
Endoscopes and Lumened Instruments: New Studies Highlight Persistent Contamination Risks
May 7th 2025Two new studies reveal troubling contamination in both new endoscopes and cleaned lumened surgical instruments, challenging the reliability of current reprocessing practices and manufacturer guidelines.
From the Derby to the Decontam Room: Leadership Lessons for Sterile Processing
April 27th 2025Elizabeth (Betty) Casey, MSN, RN, CNOR, CRCST, CHL, is the SVP of Operations and Chief Nursing Officer at Surgical Solutions in Overland, Kansas. This SPD leader reframes preparation, unpredictability, and teamwork by comparing surgical services to the Kentucky Derby to reenergize sterile processing professionals and inspire systemic change.